five

Triptolide and its clinically relevant pro-drug Minnelide target high-risk MYC amplified medulloblastoma

收藏
NIAID Data Ecosystem2026-05-01 收录
下载链接:
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1079676
下载链接
链接失效反馈
官方服务:
资源简介:
Pre-clinical validation of the triptolide's pro-drug Minnelide for the treatment of medulloblastomas classified as group 3 and harboring MYC amplifications.
创建时间:
2024-02-23
二维码
社区交流群
二维码
科研交流群
商业服务